Peter Thompson is a General Partner at OrbiMed. He has experience in executive roles at Becton-Dickinson and Chiron and co-founded Trubion Pharmaceuticals.
At firms with a similar stage, sector and check size.





One email when Peter's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckPeter Thompson is a General Partner at OrbiMed. He has experience in executive roles at Becton-Dickinson and Chiron and co-founded Trubion Pharmaceuticals.
Peter Thompson invests through OrbiMed, which writes checks of $1M to $30M+ at seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Peter in the subject. A warm intro from a founder OrbiMed backed works better.
Yale University; staff at National Cancer Institute; Chiron; Becton-Dickinson; CEO at Trubion Pharmaceuticals.
Last updated 2026-10-15. Is this you? Ask for a correction.